Earkart, a company in the Medical Equipment & Supplies industry, reported revenue of ₹31 crore and net profit of ₹1.17 crore for the September 2026 quarter.
Earkart (BSE: EARKART) closed at ₹102.00 on 20 Nov 2026, down 50.2% over the past year. Its market capitalisation is ₹140 crore and it trades at 36.9 times earnings.
Earkart an Indian tech-driven hearing healthcare company dedicated to making advanced audiology services and hearing aids more accessible, affordable, and transparent. Listed on the BSE SME platform, it operates across India and neighboring countries, specializing in both manufacturing and distributing modern digital hearing solutions
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.